RxDoctor Payments Data

Jay Shah, MD

Interventional Cardiology · Somerville, NJNPI 1285166264

Payments from drug & device makers

$6,071in general payments, 2019–2025

Across 108 payments — averaging $56.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$2K
  • Abbott$2K
  • Shockwave Medical, Inc$446
  • Medtronic$382
  • AstraZeneca$220
  • Teleflex LLC$219
  • plus $1K from 20 others

What the payments were for

  • Speaking & faculty fees$90015%
  • Travel & lodging$84314%
  • Food & beverage$4,32771%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,071 in reported general payments places this provider in the 30th percentile of 166 interventional cardiology providers in New Jersey.

See all interventional cardiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$45,822
Medicare patients
101
Services billed
381

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate14$156

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Somerville

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →